Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Long-Term Deferred Tax (2017 - 2026)

Updated

Takeda Pharmaceutical's Long-Term Deferred Tax was $3.38 billion in the quarter ended Jun 30, 2026, up 22.0% from $2.77 billion a year earlier but down 2.9% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Long-Term Deferred Tax at Takeda Pharmaceutical came in at $3.63 billion, up 49.1% from the prior year.

  • Long-Term Deferred Tax shows a five-year compound annual growth rate of 1.7% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Long-Term Deferred Tax was $2.43 billion in the year ended Mar 31, 2025 (-10.9%), $2.73 billion in the year ended Mar 31, 2024 (+0.8%), $2.71 billion in the year ended Mar 31, 2023 (-16.1%) and $3.23 billion in the year ended Mar 31, 2022 (-3.2%).
  • Quarterly Long-Term Deferred Tax has moved between $2.14 billion (the quarter ended Dec 31, 2023) and $3.48 billion (the quarter ended Mar 31, 2026) over five years.
  • Compared with a year earlier, Long-Term Deferred Tax has increased for five straight quarters, with growth averaging 14.0% over the last eight quarters.
  • The best year-over-year quarter for Long-Term Deferred Tax over five years was the quarter ended Mar 31, 2026 (growth of 43.3%); the worst was the quarter ended Sep 30, 2023 (a decline of 18.5%).
  • Per Business Quant data, TAK's Long-Term Deferred Tax in the three quarters before the quarter ended Jun 30, 2026 was $3.48 billion (quarter ended Mar 31, 2026), $2.78 billion (quarter ended Dec 31, 2025) and $2.65 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.38 Bn
Mar 31, 2026 3.48 Bn
Dec 31, 2025 2.78 Bn
Sep 30, 2025 2.65 Bn
Jun 30, 2025 2.77 Bn
Mar 31, 2025 2.43 Bn
Dec 31, 2024 2.47 Bn
Sep 30, 2024 2.27 Bn
Jun 30, 2024 2.45 Bn
Mar 31, 2024 2.66 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 2.33 Bn
Jun 30, 2023 2.74 Bn
Mar 31, 2023 2.77 Bn
Dec 31, 2022 2.54 Bn
Sep 30, 2022 2.86 Bn
Jun 30, 2022 2.98 Bn
Mar 31, 2022 3.12 Bn
Jun 30, 2021 3.14 Bn
Mar 31, 2021 3.34 Bn
API Access

Takeda Pharmaceutical Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=TAK&period=max&api_key=YOUR_API_KEY